In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
JASM is an assembler/disassembler for JVM bytecode. It provides a nice syntax for writing JVM classes in a bytecode-focused assembly language, and can also disassemble any Java .class file to JASM ...